Nov 02, 2016 12:02 pm UTC| Business
RESTON, Va., Nov. 02, 2016 -- Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear fuel development company, and AREVA NP, a leader in nuclear fuel, components and reactor services, have agreed upon key terms for the...
Nov 02, 2016 12:01 pm UTC| Business
RESTON, Va., Nov. 02, 2016 -- Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear fuel development company, and AREVA NP, a leader in nuclear fuel, components and reactor services, have agreed upon key terms for the...
NetSol Technologies to Report Fiscal 2017 First Quarter Results on November 14, 2016
Nov 02, 2016 12:01 pm UTC| Business
CALABASAS, Calif., Nov. 02, 2016 -- NetSol Technologies, Inc. (Nasdaq:NTWK), a global business services and enterprise application solutions provider to the Asset Finance and Leasing industry, will report its fiscal...
NetSol Technologies to Report Fiscal 2017 First Quarter Results on November 14, 2016
Nov 02, 2016 12:01 pm UTC| Business
CALABASAS, Calif., Nov. 02, 2016 -- NetSol Technologies, Inc. (Nasdaq:NTWK), a global business services and enterprise application solutions provider to the Asset Finance and Leasing industry, will report its fiscal...
Gridsum to Announce Third Quarter 2016 Financial Results on November 21, 2016
Nov 02, 2016 12:01 pm UTC| Business
BEIJING, Nov. 02, 2016 -- Gridsum Holding Inc. (“Gridsum” or the “Company”) (NASDAQ:GSUM), a leading provider of sophisticated data analysis software in China, today announced that it plans to release its unaudited...
Gridsum to Announce Third Quarter 2016 Financial Results on November 21, 2016
Nov 02, 2016 12:01 pm UTC| Business
BEIJING, Nov. 02, 2016 -- Gridsum Holding Inc. (“Gridsum” or the “Company”) (NASDAQ:GSUM), a leading provider of sophisticated data analysis software in China, today announced that it plans to release its unaudited...
Momenta Pharmaceuticals Reports Third Quarter 2016 Financial Results
Nov 02, 2016 12:01 pm UTC| Business
--Company appoints Scott M. Storer as SVP and CFO-- --Initiates Phase 1 trial for M834, biosimilar ORENCIA® (abatacept) candidate-- CAMBRIDGE, Mass., Nov. 02, 2016 -- Momenta Pharmaceuticals,Inc. (Nasdaq:MNTA) today...